These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22911331)

  • 21. Hemoccult screening in detecting colorectal neoplasm: sensitivity, specificity, and predictive value. Long-term follow-up in a large group practice setting.
    Allison JE; Feldman R; Tekawa IS
    Ann Intern Med; 1990 Mar; 112(5):328-33. PubMed ID: 2407166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunochemical versus guaiac occult blood stool tests: results of a community-based screening program.
    Petrelli N; Michalek AM; Freedman A; Baroni M; Mink I; Rodriguez-Bigas M
    Surg Oncol; 1994 Feb; 3(1):27-36. PubMed ID: 8186868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening of first degree relatives of patients operated for colorectal cancer: evaluation of fecal calprotectin vs. hemoccult II.
    Kristinsson J; Nygaard K; Aadland E; Barstad S; Sauar J; Hofstad B; Stray N; Stallemo A; Haug B; Ugstad M; Tøn H; Fuglerud P
    Digestion; 2001; 64(2):104-10. PubMed ID: 11684824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of ColoCARE versus Hemoccult SENSA for fecal occult blood testing in high-risk patients.
    Wise GR; Foliente RL; Chen YK
    Am J Gastroenterol; 1996 Aug; 91(8):1671-2. PubMed ID: 8759699
    [No Abstract]   [Full Text] [Related]  

  • 25. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.
    Imperiale TF; Ransohoff DF; Itzkowitz SH; Turnbull BA; Ross ME;
    N Engl J Med; 2004 Dec; 351(26):2704-14. PubMed ID: 15616205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic review with meta-analysis: faecal occult blood tests show lower colorectal cancer detection rates in the proximal colon in colonoscopy-verified diagnostic studies.
    Hirai HW; Tsoi KK; Chan JY; Wong SH; Ching JY; Wong MC; Wu JC; Chan FK; Sung JJ; Ng SC
    Aliment Pharmacol Ther; 2016 Apr; 43(7):755-64. PubMed ID: 26858128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting the effectiveness of the Finnish population-based colorectal cancer screening programme.
    Chiu SY; Malila N; Yen AM; Chen SL; Fann JC; Hakama M
    J Med Screen; 2017 Dec; 24(4):182-188. PubMed ID: 28084889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating sensitivity and sojourn time in screening for colorectal cancer: a comparison of statistical approaches.
    Prevost TC; Launoy G; Duffy SW; Chen HH
    Am J Epidemiol; 1998 Sep; 148(6):609-19. PubMed ID: 9753016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of fecal occult blood tests for detection of gastrointestinal bleeding in pediatric patients.
    Rosenthal P; Jennings MT
    Am J Gastroenterol; 1992 Nov; 87(11):1575-9. PubMed ID: 1442676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stool DNA and occult blood testing for screen detection of colorectal neoplasia.
    Ahlquist DA; Sargent DJ; Loprinzi CL; Levin TR; Rex DK; Ahnen DJ; Knigge K; Lance MP; Burgart LJ; Hamilton SR; Allison JE; Lawson MJ; Devens ME; Harrington JJ; Hillman SL
    Ann Intern Med; 2008 Oct; 149(7):441-50, W81. PubMed ID: 18838724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Toilet Paper-Based Point-Of-Care Test for the Rapid Detection of Fecal Occult Blood: Instrument Validation Study.
    Wang HY; Lin TW; Chiu SY; Lin WY; Huang SB; Hsieh JC; Chen HC; Lu JJ; Wu MH
    J Med Internet Res; 2020 Aug; 22(8):e20261. PubMed ID: 32763879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for colorectal cancer: current status in Japan.
    Saito H
    Dis Colon Rectum; 2000 Oct; 43(10 Suppl):S78-84. PubMed ID: 11052482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is it reasonable to use faecal occult blood test for colorectal cancer screening?
    Musil D; Tillich J
    Acta Univ Palacki Olomuc Fac Med; 1999; 142():119-21. PubMed ID: 10743740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests.
    Ahlquist DA; Wieand HS; Moertel CG; McGill DB; Loprinzi CL; O'Connell MJ; Mailliard JA; Gerstner JB; Pandya K; Ellefson RD
    JAMA; 1993 Mar; 269(10):1262-7. PubMed ID: 8437303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of stratifying by family history in colorectal cancer screening programs.
    Goede SL; Rabeneck L; Lansdorp-Vogelaar I; Zauber AG; Paszat LF; Hoch JS; Yong JH; van Hees F; Tinmouth J; van Ballegooijen M
    Int J Cancer; 2015 Sep; 137(5):1119-27. PubMed ID: 25663135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mean sojourn time of preclinical gastric cancer in Korean men: a retrospective observational study.
    Bae JM; Shin SY; Kim EH
    J Prev Med Public Health; 2014 Jul; 47(4):201-5. PubMed ID: 25139166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of upper gastrointestinal blood with fecal occult blood tests.
    Rockey DC; Auslander A; Greenberg PD
    Am J Gastroenterol; 1999 Feb; 94(2):344-50. PubMed ID: 10022627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population colorectal cancer screening with fecal occult blood test.
    Rennert G; Rennert HS; Miron E; Peterburg Y
    Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1165-8. PubMed ID: 11700264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for colorectal cancer using the faecal occult blood test, hemoccult.
    Towler BP; Irwig L; Glasziou P; Weller D; Kewenter J
    Cochrane Database Syst Rev; 2000; (2):CD001216. PubMed ID: 10796760
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.